EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS

Marco Riebel, Benedikt von Pappenheim, Carolina Kanig, Caroline Nothdurfter, Thomas C Wetter, Rainer Rupprecht, Jens Schwarzbach

Pharmacopsychiatry · 01.07.2023 · 56 (04) · 154-161

DOI: 10.1055/a-2078-4823 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pharmacopsychiatry, erschienen am 01.07.2023. Verfasst von Marco Riebel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, University of Regensburg, Germany. Hauptthemen laut MEDLINE: Motor Cortex, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is a need for novel anxiolytics with improved side effect profiles compared to benzodiazepines. A promising candidate with alternative pharmacodynamics is the translocator protein ligand, etifoxine.

Methods

To get further insight into its mechanisms of action and side effects compared to the benzodiazepine alprazolam, we performed a double-blind, placebo-controlled, repeated-measures study in 36 healthy male subjects. Participants were examined for trait anxiety and side effects and underwent repeated transcranial magnetic stimulation (TMS) assessments, including motor evoked potentials (MEP), short intracortical inhibition (SICI), intracortical facilitation (ICF), and cortical silent period (CSP).

Results

We observed attenuation of MEPs by alprazolam but not by etifoxine. SICI was not significantly affected by alprazolam or etifoxine. However, the response pattern indicated a lowered SICI threshold after the administration of etifoxine and alprazolam compared to the placebo. ICF and CSP were influenced by neither medication. Alprazolam led to higher sedation and subjective impairment of concentration compared to etifoxine. Individual anxiety trait scores did not affect TMS parameters.

Discussion

This study indicated a favorable side effect profile of etifoxine in healthy volunteers. Moreover, it revealed differential GABA-related effects on neuromuscular function by means of TMS. The side effects and TMS profile of etifoxine are compatible with the involvement of neurosteroidogenesis and a predominant α3 subunit modulation compared to alprazolam.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Motor CortexDrug-Related Side Effects and Adverse ReactionsHumansMaleAlprazolamTranscranial Magnetic StimulationGABA AgentsOxazines

Substanzen

AlprazolamGABA AgentsetifoxineOxazines

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, University of Regensburg, Germany.

Zitieren

APA

Riebel, M., von Pappenheim, B., Kanig, C., Nothdurfter, C., Wetter, T. C., Rupprecht, R., & Schwarzbach, J. (2023). GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS. Pharmacopsychiatry, 56(04), 154-161. https://doi.org/10.1055/a-2078-4823

Vancouver

Riebel M, von Pappenheim B, Kanig C, Nothdurfter C, Wetter TC, Rupprecht R, et al. GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS. Pharmacopsychiatry. 2023;56(04):154-161. doi:10.1055/a-2078-4823

BibTeX
@article{Riebel2023,
  author = {Riebel, Marco and von Pappenheim, Benedikt and Kanig, Carolina and Nothdurfter, Caroline and Wetter, Thomas C and Rupprecht, Rainer and Schwarzbach, Jens},
  title = {GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS},
  journal = {Pharmacopsychiatry},
  year = {2023},
  volume = {56},
  number = {04},
  pages = {154--161},
  doi = {10.1055/a-2078-4823}
}
Kostenlos starten →